Hugel Inc., a leading global medical aesthetics company, hosted its global medical symposium H.E.L.F. in Seoul 2025 at Seoul Dragon City on September 14 to commemorate the 15th anniversary of the launch of its botulinum toxin Letybo.H.E.L.F., or Hugel Expert Leader’s Forum, has served as the company
Hugel Inc., a leading global medical aesthetics company chaired by Suk Cha, is accelerating its growth in Brazil – one of Latin America’s key markets – through a distribution agreement with Derma Dream for its botulinum toxin product Letybo.Derma Dream is a leading aesthetics company in Brazil with
Hugel Inc., a leading global medical aesthetics company chaired by Suk Cha, has officially launched its botulinum toxin product Letybo in Malaysia – an emerging market for medical aesthetics in Southeast Asia.The company’s Malaysian partner Venusys Medical Sdn Bhd introduced Letybo at the Aesthetic
바이오텍 시장 환경이 급변하면서 투자 유치 경쟁이 그 어느 때보다 치열해지고 있다. 이에 따라 초기 단계 바이오텍들에게 '실행력'의 중요성이 부각되고 있다. 신약 개발의 여정은 '유망한 파이프라인'에서 출발하지만 '자본'이 없으면 그 여정은 결코 이뤄질 수 없는 까닭이다.최근 IQVIA가 발표한 '초기 단계 바이오텍의 리스크 제거: 비전을 벤처 캐피털로 전환'이라는 보고서에 따르면, 우수한 리드 후보물질의 확보가 중요한 출발점이지만, 그 자체로는 시장성과 투자 유치가 보장되지 않는다고 강조한다.즉, 단순히 좋은 파이프라인을 보유하는
Hugel Inc., a leading global medical aesthetics company, successfully hosted a launch event for its botulinum toxin product Botulax in the United Arab Emirates on May 9 at Desert Rose Yacht, Dubai.This event, following the product’s debut in Kuwait, marked the second official launch in the Middle Ea
Hugel Inc., a leading global medical aesthetics company chaired by Suk Cha, on May 8 posted KRW89.8 billion, KRW39.0 billion, and KRW30.9 billion for the first quarter net sales, operating profit, and net profit, respectively, based on a consolidated financial statement. With the highest-ever first-
Hugel Inc., a leading global medical aesthetics company, has recently hosted a launch seminar for its botulinum toxin Botulax and hyaluronic acid dermal filler Revolax at Holiday Inn Almaty, Kazakhstan, for local dermatologists and plastic surgeons.Kazakhstan, the largest country in Central Asia, is
Hugel Inc., a leading global medical aesthetics company, held its 24th annual shareholders meeting at Sejong Hotel in Chuncheon, the city where the company is headquartered, on March 31.The meeting approved six resolutions including the financial statements for 2024, the appointment of board directo
Hugel Inc., a leading global medical aesthetics company, held a Board of Directors meeting on March 14, 2025 and appointed Chulmin Park as Representative Executive Officer. Park will succeed Seonho Hahn.Park joined Hugel in 2018 and has been serving as the head of business operations, overseeing HR
Hugel Inc., a leading global medical aesthetics company chaired by Suk Cha, posted record-breaking earnings in 2024 with KRW373.0 billion in net sales and KRW166.3 billion in operating profit, respectively up 16.7% and 41.2% year-over-year. Net income increased 45.8% on-year to KRW142.4 billion.In t
